CLINICAL_TRIALS
trial_result
· 2025-01-20
Clinical Trial Update: Study to Assess Safety and Efficacy of Engensis in Painful Diabetic Peripheral Neuropathy [Phase 3]
Summary
A Phase 3 study of Engensis for painful diabetic neuropathy has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Helixmith Co., Ltd. | Conditions: Diabetic Neuropathy, Painful | Phase 3 | Status: COMPLETED | Results posted: 2025-01-20